The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues
The interdisciplinary interim experts’ counsil on March 3, 2016 in Moscow have considered the EMPA-REG OUTCOME trial results and suggested a number of prorositions and remommendations on further empagliflozin’s cardiovascular effects investigation and it’s clinical appl...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2016-05-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/7968 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850141116802793472 |
|---|---|
| author | Editorial team Diabetes Mellitus |
| author_facet | Editorial team Diabetes Mellitus |
| author_sort | Editorial team Diabetes Mellitus |
| collection | DOAJ |
| description | The interdisciplinary interim experts’ counsil on March 3, 2016 in Moscow have considered the EMPA-REG OUTCOME trial results and suggested a number of prorositions and remommendations on further empagliflozin’s cardiovascular effects investigation and it’s clinical application in patients with type 2 diabetes at high cardiovascular risk. |
| format | Article |
| id | doaj-art-5f7ca36e59854d25a5d206eef64bffb3 |
| institution | OA Journals |
| issn | 2072-0351 2072-0378 |
| language | English |
| publishDate | 2016-05-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj-art-5f7ca36e59854d25a5d206eef64bffb32025-08-20T02:29:34ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782016-05-0119218218510.14341/DM2004156-617401The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issuesEditorial team Diabetes MellitusThe interdisciplinary interim experts’ counsil on March 3, 2016 in Moscow have considered the EMPA-REG OUTCOME trial results and suggested a number of prorositions and remommendations on further empagliflozin’s cardiovascular effects investigation and it’s clinical application in patients with type 2 diabetes at high cardiovascular risk.https://www.dia-endojournals.ru/jour/article/view/7968empaglflozintype 2 diabetes mellituscardiovascular diseasemortalityempa-reg outcome trial |
| spellingShingle | Editorial team Diabetes Mellitus The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues Сахарный диабет empaglflozin type 2 diabetes mellitus cardiovascular disease mortality empa-reg outcome trial |
| title | The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues |
| title_full | The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues |
| title_fullStr | The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues |
| title_full_unstemmed | The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues |
| title_short | The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues |
| title_sort | interim experts counsil resolution on the empa reg outcome trial issues |
| topic | empaglflozin type 2 diabetes mellitus cardiovascular disease mortality empa-reg outcome trial |
| url | https://www.dia-endojournals.ru/jour/article/view/7968 |
| work_keys_str_mv | AT editorialteamdiabetesmellitus theinterimexpertscounsilresolutionontheemparegoutcometrialissues AT editorialteamdiabetesmellitus interimexpertscounsilresolutionontheemparegoutcometrialissues |